🎉We have received funding from @kwf_nl for a large randomized trial investigating upfront dose-reduced #chemotherapy in #older patients with metastatic colorectal cancer! 🎉. @NienkedeGlas @JoPortielje @LUMC_Leiden #LUMC.

RT @SIOGorg: 🗣️ 3 weeks to go! Submit your abstract for #SIOG2025 and be part of the global conversation on improving #CancerCare for older….

RT @JGeriOnc: Perspectives on prehabilitation for older adults with cancer: A report from the International Society of Geriatric Oncology (….

RT @JGeriOnc: Systemic treatment among frail older patients with cancer: An observational cohort @WilliamDale_MD @m….

RT @JGeriOnc: Treatment outcomes in older patients presenting to a radiation oncology clinic based on an electronic health record-based fra….

RT @EnriqueSoto8: Glad to see the wonderful SONIA trial published in Nature! #bcsm Great data to guide treatment decision making and health….

RT @EnriqueSoto8: @OncJournal @SIOGorg @CancerCareMASCC @JCBaltussen @UniLeidenNews @CUCancerCenter @INCMNSZ_Geria The most commonly measur….

RT @EnriqueSoto8: Our systematic review on the use of #wearable technologies in older adults with #cancer is out in @OncJournal #gerionc #g….

⌚️📱Wearables show great potential in geriatric oncology care, but an overview of their use was lacking-until now!. 🚨Just published in @OncJournal : our systematic review on wearables in older adults with cancer, including recommendations .@EnriqueSoto8 .

RT @selcukorkmaz: Understanding the difference between Standard Deviation (SD) and Standard Error (SE) is crucial for accurate data interpr….

RT @oncology_bg: Oncologists’ perceptions of PFS. These quotes are gold.

RT @SIOGorg: 📅 Save the Date! SIOG’s Research Masterclass on Geriatric Oncology March 19 - 21, 2025!.Expand your study toolkit & profession….

RT @JGeriOnc: Association of Glasgow Prognostic Score with frailty, mortality and adverse health outcomes in older patients with cancer: A….

🚀 Already looking forward to the results of the IMPORTANT-trial, investigating lower starting doses of #CDK4/6 inhibitors and the role of the #geriatric assessment in older adults with mBC . Congratulations to the authors for enrolling this study!.

RT @YoungSIOG: Meet the new YSIOG Governance Team of 2024-2026!.2️⃣0️⃣2️⃣4️⃣-2️⃣0️⃣2️⃣6️⃣.

RT @Decoster_Lore: Happy to invite you all to the beautiful city of Ghent for the 2025 Annual meeting of SIOG. #SIOG2024 .

RT @geriatric_onc: Amazing work from Young SIOG members with research with 61 articles published. Keep up the great work @YoungSIOG @SIOGor….

RT @FabioGomes_Go: 🍁🇨🇦 Great gathering by @YoungSIOG in Montreal for #SIOG2024 . Thanks everyone for joining and big thanks to the 2022-202….

RT @Dr_F_Coutinho: Great work from @IndiaPinker . Very happy to be part of talented team. Congrats!. @SIOGorg Annual Conference.#SIOG2024 h….

🚀Excited to share our #DOSAGE trial protocol, exploring dose-reduced chemotherapy in older adults with mCRC and its impact on survival, toxicity, and QoL, published in @BMJ_Open!.🏥 The trial has already been launched in 10 centers. Check it out here:.

RT @YoungSIOG: 🚀 Just 1 week until the #SIOG2024 conference in Montréal!. Don’t miss out on our YSIOG activities - no pre-registration need….